The study, published in the Journal of the American College of Cardiology, used Merck & Co., Inc. (NYSE:MRK)'s Zocor, but it seems safe to assume that other statins -- Pfizer Inc. (NYSE:PFE)'s Lipitor and AstraZeneca plc (ADR) (NYSE:AZN)'s Crestor ...
Related articles »